- Home
- SMBC vs SANA Comparison
SMBC vs SANA Comparison
Compare SMBC & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SMBC | SANA |
|---|---|---|
| Founded | 1887 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 764.5M | 688.5M |
| IPO Year | 2011 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SMBC | SANA |
|---|---|---|
| Price | $72.25 | $2.41 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 9 |
| Target Price | ★ $78.40 | $8.43 |
| AVG Volume (30 Days) | 70.8K | ★ 3.0M |
| Earning Date | 10-21-2026 | 11-13-2026 |
| Dividend Yield | ★ 1.53% | N/A |
| EPS Growth | ★ 24.13 | 17.24 |
| EPS | ★ 6.43 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.94 | N/A |
| Revenue Next Year | $3.20 | N/A |
| P/E Ratio | $11.03 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $52.52 | $2.22 |
| 52 Week High | $79.86 | $5.49 |
Technical Indicators
Market Signals| Indicator | SMBC | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 54.35 | 39.67 |
| Support Level | $69.90 | $2.22 |
| Resistance Level | $78.94 | $3.41 |
| Average True Range (ATR) | 1.43 | 0.16 |
| MACD | 0.24 | 0.04 |
| Stochastic Oscillator | 71.10 | 33.77 |
Price Performance
Historical ComparisonAbout SMBC Southern Missouri Bancorp Inc.
Southern Missouri Bancorp Inc is a USA-based holding company for Southern Missouri Savings Bank. The principal business of the bank consists of attracting retail deposits from the general public and using such deposits along with wholesale funding from the Federal Home Loan Bank of Des Moines, and to a lesser extent, brokered deposits, to invest in one- to four-family residential mortgage loans, mortgage loans secured by commercial real estate, commercial non-mortgage business loans, and consumer loans. It is engaged in providing the range of banking and financial services to individuals and corporate customers in its market areas. The company derives revenue principally from interest on loans, debt securities, bank card interchange fees, loan late charges and another fee income.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.